Day

October 30, 2020
NTM Info & Research (NTMir), the national nonprofit organization advocating on behalf of patients with nontuberculous mycobacterial (NTM) lung disease, applauds the European Commission’s decision to grant marketing authorization for ARIKAYCE® Liposomal 590 mg Nebuliser Dispersion (“ARIKAYCE”) for the treatment of nontuberculous mycobacterial (NTM) lung infections caused by Mycobacterium avium complex (MAC) in adults with...
Read More

WHAT IS NTM?

“NTM” is short for Nontuberculous Mycobacteria. NTM disease is a serious chronic lung illness.

Learn More